HCA Healthcare's Schlosser sells 1,200 shares

Executions ranged from $494.63 to $494.70 per share, and the sale price was reported as a weighted average.

Available on EDGAR 11/06/2026 - 05:12 PM EST Accepted by SEC EDGAR 11/06/2026 - 05:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

HCA Healthcare, Inc. EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares of Common Stock on November 4, 2026, at a reported weighted average price of $494.6524 per share. He directly held 1,443 shares after the sale; a separate entry lists 6,951 shares held indirectly through the 2022 Trust. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 1,200 shares

Net Sell 1 txn

Insider Schlosser Michael J

Role EVP and Chief Clinical Officer

Sold 1,200 shs ($594K)

Share of Position Sold 45.4%

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,200	$494.6524	$594K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,443.1027 shares (Direct); Common Stock — 6,951 shares (Indirect, By 2022 Trust)

Holdings Before and After: Common Stock, 2,643.1027 to 1,443.1027 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.63 to $494.70, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 1,200 shares Weighted average sale price: $494.6524 per share Transaction price range: $494.63–$494.70 per share +2 more

5 metrics

Shares sold 1,200 shares Common Stock sale on November 4, 2026

Weighted average sale price $494.6524 per share November 4, 2026 sale

Transaction price range $494.63–$494.70 per share Multiple transactions; range is inclusive

Direct shares held after sale 1,443 shares Following the November 4, 2026 transaction

Shares held through the 2022 Trust 6,951 shares Indirect holding listed on November 4, 2026

Key Terms

weighted average price, open market or private transaction

2 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HCA shares did Michael J. Schlosser sell?

Michael J. Schlosser sold 1,200 shares of HCA Common Stock on November 4, 2026, at a weighted average of $494.6524 per share. The shares were sold in multiple transactions priced from $494.63 to $494.70, inclusive. No Rule 10b5-1 plan is reported.

How many HCA shares did Michael J. Schlosser hold after the sale?

After the sale, Michael J. Schlosser directly held 1,443 shares. A separate entry lists 6,951 shares held indirectly through the 2022 Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schlosser Michael J

(Last) (First) (Middle)

ONE PARK PLAZA

(Street)

NASHVILLE TENNESSEE 37203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Clinical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2026		S		1,200	D	$494.6524(1)	1,443.1027	D
Common Stock								6,951	I	By 2022 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.63 to $494.70, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Kevin A. Ball, Attorney-in-Fact	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)